• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名同时患有化脓性汗腺炎和播散性掌跖汗孔角化症的患者:病例报告及自身炎症性角化病综述

A Patient With Concurrent Hidradenitis Suppurativa and Porokeratosis Palmaris et Plantaris Disseminata: Case Report and Review of Autoinflammatory Keratinization Diseases.

作者信息

Rogers Meredith C, Ash Mark, Hernandez Amanda, Hosler Gregory A

机构信息

Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Empire Dermatology, Syracuse, New York, USA.

出版信息

J Cutan Pathol. 2025 Apr;52(4):272-277. doi: 10.1111/cup.14774. Epub 2025 Jan 3.

DOI:10.1111/cup.14774
PMID:39749894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11885075/
Abstract

The term autoinflammatory keratinization diseases (AIKDs) was recently proposed as a unifying concept for diseases characterized by inflammation in the epidermis and upper dermis which leads to hyperkeratosis, caused by genetic perturbations of the innate immune system. We present a case of a patient with hidradenitis suppurativa and porokeratosis, two AIKDs, followed by a review of these conditions as well as other AIKDs. This case was distinguished by hypertrophic porokeratoses involving cystic hair follicles, showing histopathologic features of both conditions within single biopsy specimens. The patient's course was additionally complicated by SCC arising within a porokeratosis. Our case demonstrates a rare overlap of two AIKDs, occurring not only within the same patient but also within the same lesions.

摘要

自身炎症性角化病(AIKDs)这一术语最近被提出,作为一种统一的概念,用于描述由先天性免疫系统的基因扰动导致的、以表皮和真皮上层炎症并进而引起角化过度为特征的疾病。我们报告一例患有化脓性汗腺炎和汗孔角化症这两种AIKDs的患者病例,随后对这些病症以及其他AIKDs进行综述。该病例的特征是肥厚性汗孔角化症累及囊性毛囊,在单个活检标本中显示出两种病症的组织病理学特征。此外,患者病程因汗孔角化症内发生鳞状细胞癌而复杂化。我们的病例展示了两种AIKDs罕见的重叠情况,不仅发生在同一患者身上,还出现在同一病变内。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ac/11885075/24921777a45d/CUP-52-272-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ac/11885075/5941c9b05e81/CUP-52-272-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ac/11885075/d688e494cb92/CUP-52-272-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ac/11885075/1ca9a57b5302/CUP-52-272-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ac/11885075/7bdbc1c3c637/CUP-52-272-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ac/11885075/24921777a45d/CUP-52-272-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ac/11885075/5941c9b05e81/CUP-52-272-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ac/11885075/d688e494cb92/CUP-52-272-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ac/11885075/1ca9a57b5302/CUP-52-272-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ac/11885075/7bdbc1c3c637/CUP-52-272-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59ac/11885075/24921777a45d/CUP-52-272-g002.jpg

相似文献

1
A Patient With Concurrent Hidradenitis Suppurativa and Porokeratosis Palmaris et Plantaris Disseminata: Case Report and Review of Autoinflammatory Keratinization Diseases.一名同时患有化脓性汗腺炎和播散性掌跖汗孔角化症的患者:病例报告及自身炎症性角化病综述
J Cutan Pathol. 2025 Apr;52(4):272-277. doi: 10.1111/cup.14774. Epub 2025 Jan 3.
2
Diseases categorized as autoinflammatory keratinization diseases (AiKDs), and their pathologies and treatments.归类为自身炎症性角化病(Autoinflammatory Keratinization Diseases,AiKDs)的疾病,以及它们的病理和治疗方法。
Nagoya J Med Sci. 2024 Feb;86(1):1-15. doi: 10.18999/nagjms.86.1.1.
3
Porokeratosis Plantaris, Palmaris et Disseminata Caused by Con- genital Pathogenic Variants in the MVD Gene and Loss of Hetero-zygosity in Affected Skin.由MVD基因先天性致病变异及受累皮肤杂合性缺失引起的跖部、掌部播散性汗孔角化症
Acta Derm Venereol. 2021 Feb 16;101(2):adv00397. doi: 10.2340/00015555-3753.
4
Porokeratosis palmaris et plantaris disseminata or a disseminated late-onset variant of porokeratotic eccrine ostial and dermal ductal nevus (PEODDN) with follicular involvement.播散性掌跖汗孔角化症或伴有毛囊受累的汗孔角化性小汗腺导管口及真皮导管痣(PEODDN)的播散性迟发型变异型。
Dermatol Online J. 2009 Aug 15;15(8):8.
5
Squamous cell carcinoma arising from lesions of porokeratosis palmaris et plantaris disseminata.掌跖播散性汗孔角化症病变引发的鳞状细胞癌。
Eur J Dermatol. 2000 Aug;10(6):478-80.
6
Porokeratoses-A Rare Group of Dermatoses.角化不良症——一组罕见的皮肤病。
Medicina (Kaunas). 2024 Nov 16;60(11):1876. doi: 10.3390/medicina60111876.
7
Autoinflammatory Keratinization Diseases (AiKDs): Expansion of Disorders to Be Included.自身炎症性角化病(AiKDs):纳入疾病范围的扩展
Front Immunol. 2020 Feb 21;11:280. doi: 10.3389/fimmu.2020.00280. eCollection 2020.
8
[Porokeratosis plantaris, palmaris et disseminataa with multiple filiform hyperkeratoses and nail dystrophy].掌跖播散性汗孔角化症伴多发丝状角化过度及甲营养不良
Hautarzt. 1995 Dec;46(12):869-72. doi: 10.1007/s001050050357.
9
Lack of TP53 mutations in a case of porokeratosis palmaris, plantaris et disseminata.播散性掌跖角化病一例中未检测到TP53突变。
Dermatology. 2000;201(2):158-61. doi: 10.1159/000018462.
10
Porokeratosis palmaris et plantaris disseminata. Report of a case with abnormal DNA ploidy in lesional epidermis.播散性掌跖汗孔角化症。1例皮损表皮DNA倍体异常的病例报告。
Arch Dermatol. 1992 Feb;128(2):236-9. doi: 10.1001/archderm.128.2.236.

本文引用的文献

1
Concomitance of Hidradenitis Suppurativa and Porokeratoses.化脓性汗腺炎与汗孔角化症的伴发情况。
J Clin Aesthet Dermatol. 2023 Apr;16(4):28-31.
2
Successful treatment with anakinra in generalized spiculated porokeratosis and severe hidradenitis suppurativa in a patient with MVK and MEFV mutations.一名患有MVK和MEFV突变的患者,使用阿那白滞素成功治疗泛发性棘状汗孔角化症和重度化脓性汗腺炎。
Clin Exp Dermatol. 2023 Feb 2;48(2):161-165. doi: 10.1093/ced/llac023.
3
Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease.
生物制剂和/或小分子药物联合治疗炎症性肠病患者的作用。
World J Gastroenterol. 2022 Dec 21;28(47):6743-6751. doi: 10.3748/wjg.v28.i47.6743.
4
Case report: JAKi and TNFi dual therapy is a potential treatment strategy for difficult-to-treat rheumatoid arthritis.病例报告:JAKi 和 TNFi 双重治疗是一种治疗难治性类风湿关节炎的潜在治疗策略。
Front Immunol. 2022 Dec 14;13:1074329. doi: 10.3389/fimmu.2022.1074329. eCollection 2022.
5
Dermatologic Disease-Directed Targeted Therapy (DT): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions-Precision Dermatology.皮肤病定向靶向治疗(DT):基于生物标志物的精准医学在皮肤病个性化治疗中的应用——精准皮肤病学。
Dermatol Ther (Heidelb). 2022 Oct;12(10):2249-2271. doi: 10.1007/s13555-022-00801-2. Epub 2022 Sep 19.
6
Hidradenitis Suppurativa: A Perspective on Genetic Factors Involved in the Disease.化脓性汗腺炎:关于该疾病相关遗传因素的观点。
Biomedicines. 2022 Aug 21;10(8):2039. doi: 10.3390/biomedicines10082039.
7
Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.生物制剂与口服小分子药物治疗炎症性肠病严重感染风险的比较:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2023 Apr;21(4):907-921.e2. doi: 10.1016/j.cgh.2022.07.032. Epub 2022 Aug 6.
8
Case Report: Comorbid Hyper-IgD Syndrome and Hidradenitis Suppurativa - A New Syndromic Form of HS? A Report of Two Cases.病例报告:合并高IgD综合征和化脓性汗腺炎——一种新的化脓性汗腺炎综合征形式?两例报告
Front Immunol. 2022 May 26;13:883811. doi: 10.3389/fimmu.2022.883811. eCollection 2022.
9
Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis.化脓性汗腺炎患病率的系统评价和荟萃回归分析。
JAMA Dermatol. 2021 Aug 1;157(8):924-931. doi: 10.1001/jamadermatol.2021.1677.
10
Drugs associated with development of porokeratosis: A systematic review.与汗孔角化症发生相关的药物:系统评价。
Dermatol Ther. 2021 Jan;34(1):e14560. doi: 10.1111/dth.14560. Epub 2020 Dec 1.